The Europe Head And Neck Cancer Therapeutics Market would witness market growth of 11.6% CAGR during the forecast period (2022-2028).
The risk of dissemination to other areas of the body via the bloodstream is directly connected to whether cancer has progressed to the lymph nodes in the neck, the number of lymph nodes involved, and the location of the lymph nodes in the neck. The risk is greater if cancer is present in lymph nodes in the lower neck, as opposed to merely those in the upper neck.
The detection of cancer of the head and neck is frequently established by a dentist, oral surgeon, or physician when a patient detects signs such as a lump in the neck or a nonhealing sore in the mouth. During a normal examination, the diagnosis can be determined even in the absence of symptoms.
Head and neck cancer encompass epithelial malignancies of the upper aerodigestive tract (UADT), which includes the paranasal sinuses, oral cavity, nasal cavity pharynx, and larynx; and as the sixth most prevalent cancer worldwide, head and neck cancer accounts for approximately 6% of solid tumors. Annually, around 650,000 new cases of head and neck cancer are detected, resulting in approximately 350,000 deaths.
The incidence of neck dissection is a quality measure for the treatment of oral cavity cancer at Germany's approved head and neck cancer clinics. Neck dissections will be performed on 76% of oral cavity cancer cases treated in accredited facilities. Healthcare expenditures in the United Kingdom have climbed by 4% annually. In 1960, it represented less than 5% of the gross domestic product (GDP); fifty years later, it represents over 10% of the GDP. Current projections indicate that within ten years, unmanaged healthcare spending will outpace economic growth and become unsustainable.
The Germany market dominated the Europe Head & Neck Cancer Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $165 Million by 2028. The UK market is anticipated to grow at a CAGR of 10.7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.4% during (2022 - 2028).
Based on Therapy Type, the market is segmented into Immunotherapy, Chemotherapy, and Targeted Therapy. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Head And Neck Cancer Therapeutics Market will Hit $2.5 Billion by 2028, at a CAGR of 12.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
- Immunotherapy
- Chemotherapy
- Targeted Therapy
By Route of Administration
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca Plc
- Bristol Myers Squibb Company
- Clinigen Group PLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Head & Neck Cancer Therapeutics Market, by Therapy Type
1.4.2 Europe Head & Neck Cancer Therapeutics Market, by Route of Administration
1.4.3 Europe Head & Neck Cancer Therapeutics Market, by Distribution Channel
1.4.4 Europe Head & Neck Cancer Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Head And Neck Cancer Therapeutics Market
Chapter 4. Europe Head & Neck Cancer Therapeutics Market by Therapy Type
4.1 Europe Immunotherapy Market by Country
4.2 Europe Chemotherapy Market by Country
4.3 Europe Targeted Therapy Market by Country
Chapter 5. Europe Head & Neck Cancer Therapeutics Market by Route of Administration
5.1 Europe Injectable Market by Country
5.2 Europe Oral Market by Country
Chapter 6. Europe Head & Neck Cancer Therapeutics Market by Distribution Channel
6.1 Europe Retail & Specialty Pharmacies Market by Country
6.2 Europe Hospital Pharmacies Market by Country
6.3 Europe Online Pharmacies Market by Country
Chapter 7. Europe Head & Neck Cancer Therapeutics Market by Country
7.1 Germany Head & Neck Cancer Therapeutics Market
7.1.1 Germany Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.2 Germany Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.3 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2 UK Head & Neck Cancer Therapeutics Market
7.2.1 UK Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.2 UK Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.3 UK Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3 France Head & Neck Cancer Therapeutics Market
7.3.1 France Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.2 France Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.3 France Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4 Russia Head & Neck Cancer Therapeutics Market
7.4.1 Russia Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.2 Russia Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.3 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel
7.5 Spain Head & Neck Cancer Therapeutics Market
7.5.1 Spain Head & Neck Cancer Therapeutics Market by Therapy Type
7.5.2 Spain Head & Neck Cancer Therapeutics Market by Route of Administration
7.5.3 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel
7.6 Italy Head & Neck Cancer Therapeutics Market
7.6.1 Italy Head & Neck Cancer Therapeutics Market by Therapy Type
7.6.2 Italy Head & Neck Cancer Therapeutics Market by Route of Administration
7.6.3 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel
7.7 Rest of Europe Head & Neck Cancer Therapeutics Market
7.7.1 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type
7.7.2 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration
7.7.3 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.2 Merck & Co., Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Takeda Pharmaceutical Company Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Bristol Myers Squibb Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Clinigen Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
TABLE 1 Europe Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Europe Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 4 Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 5 Europe Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 Europe Injectable Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Injectable Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 Europe Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 27 Germany Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 Germany Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 Germany Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 Germany Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 Germany Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 32 Germany Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 33 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 Germany Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 UK Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 36 UK Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 37 UK Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 38 UK Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 39 UK Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 40 UK Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 41 UK Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 UK Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 France Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 44 France Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 45 France Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 46 France Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 47 France Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 48 France Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 49 France Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 France Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 Russia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 52 Russia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 53 Russia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 54 Russia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 55 Russia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 56 Russia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 57 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Russia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Spain Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 Spain Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 Spain Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 62 Spain Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 63 Spain Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 64 Spain Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 65 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Spain Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Italy Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 68 Italy Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 69 Italy Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 70 Italy Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 71 Italy Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 72 Italy Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 73 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Italy Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Rest of Europe Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 76 Rest of Europe Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 77 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 78 Rest of Europe Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Key Information – Eli Lilly And Company
TABLE 84 KEY INFORMATION - MERCK & CO., INC.
TABLE 85 Key Information – Sanofi S.A.
TABLE 86 Key Information – Takeda Pharmaceutical Company Limited
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 89 KEY INFORMATION – AstraZeneca PLC
TABLE 90 Key Information – Bristol Myers Squibb Company
TABLE 91 Key Information – Clinigen Group PLC
List of Figures
FIG 1 Methodology for the research